BSE Live
Jan 21, 16:01Prev. Close
824.05
Open Price
819.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:57Prev. Close
822.75
Open Price
819.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
839.75 (941)
| Balance Sheet of Natco Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 36.40 | 36.50 | 36.90 | 34.90 | 34.80 | |
| Total Share Capital | 36.40 | 36.50 | 36.90 | 34.90 | 34.80 | |
| Reserves and Surplus | 3,833.10 | 3,526.70 | 3,088.50 | 1,664.80 | 1,301.50 | |
| Total Reserves and Surplus | 3,833.10 | 3,526.70 | 3,088.50 | 1,664.80 | 1,301.50 | |
| Total Shareholders Funds | 3,869.50 | 3,563.20 | 3,125.40 | 1,699.70 | 1,336.30 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 25.60 | 11.30 | 13.80 | 15.00 | 14.60 | |
| Other Long Term Liabilities | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | |
| Long Term Provisions | 90.20 | 71.00 | 32.40 | 21.90 | 12.50 | |
| Total Non-Current Liabilities | 117.50 | 83.10 | 47.00 | 37.70 | 27.90 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 313.10 | 384.50 | 173.00 | 220.60 | 96.00 | |
| Trade Payables | 234.20 | 201.80 | 245.40 | 251.40 | 270.10 | |
| Other Current Liabilities | 101.90 | 114.50 | 131.70 | 135.90 | 110.90 | |
| Short Term Provisions | 10.50 | 9.00 | 13.70 | 1.80 | 1.50 | |
| Total Current Liabilities | 659.70 | 709.80 | 563.80 | 609.70 | 478.50 | |
| Total Capital And Liabilities | 4,646.70 | 4,356.10 | 3,736.20 | 2,347.10 | 1,842.70 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,565.70 | 1,206.70 | 1,009.60 | 823.40 | 700.30 | |
| Intangible Assets | 8.80 | 8.20 | 5.70 | 5.60 | 5.30 | |
| Capital Work-In-Progress | 517.80 | 637.50 | 480.00 | 336.20 | 211.90 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2,092.30 | 1,852.40 | 1,495.30 | 1,165.20 | 917.50 | |
| Non-Current Investments | 186.10 | 117.60 | 101.30 | 85.90 | 71.70 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 68.40 | 49.60 | 7.80 | 0.00 | 0.00 | |
| Other Non-Current Assets | 60.00 | 69.10 | 77.60 | 60.90 | 62.60 | |
| Total Non-Current Assets | 2,406.80 | 2,088.70 | 1,682.00 | 1,312.00 | 1,051.80 | |
| CURRENT ASSETS | ||||||
| Current Investments | 5.00 | 126.80 | 48.30 | 8.90 | 22.10 | |
| Inventories | 524.40 | 508.40 | 425.80 | 336.90 | 351.90 | |
| Trade Receivables | 536.70 | 491.60 | 606.00 | 468.90 | 255.80 | |
| Cash And Cash Equivalents | 54.10 | 262.70 | 172.10 | 25.10 | 40.20 | |
| Short Term Loans And Advances | 8.10 | 7.00 | 4.60 | 6.60 | 2.80 | |
| OtherCurrentAssets | 1,111.60 | 870.90 | 797.40 | 188.70 | 118.10 | |
| Total Current Assets | 2,239.90 | 2,267.40 | 2,054.20 | 1,035.10 | 790.90 | |
| Total Assets | 4,646.70 | 4,356.10 | 3,736.20 | 2,347.10 | 1,842.70 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 98.80 | 78.10 | 108.00 | 63.20 | 40.40 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 181.78 | 293.90 | 297.84 | 0.00 | 51.96 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 314.13 | |
| Other Earnings | 873.61 | 1,153.60 | 1,032.18 | -- | 31.61 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.73 | 5.75 | 5.81 | 5.81 | 5.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 51.20 | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 33.50 | 19.90 | 8.10 | 85.90 | 71.70 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 5.00 | 6.80 | 8.30 | 8.90 | 2.10 | |
| Current Investments Unquoted Book Value | 6.00 | 120.00 | 40.00 | -- | 20.00 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y